Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Sichuan Kelun Pharmaceutical Research Institute Co., Ltd."
Count: 19
Selected: 0
| NCT ID | Title |
|---|
| NCT05870319 | A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients | ||
| NCT05631262 | SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors | ||
| NCT05367635 | A Study of SKB315 in Patients With Advanced Solid Tumors | ||
| NCT06081959 | A Phase III Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer | ||
| NCT05906537 | SKB410 for Injection in Solid Tumors | ||
| NCT05265091 | A Study of KL590586 in Patients With Advanced Solid Tumors | ||
| NCT05549804 | A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors | ||
| NCT05496426 | A Study of KL130008 in Adults With Severe Alopecia Areata | ||
| NCT05387928 | A Study of KL340399 in Patients With Advanced Solid Tumors | ||
| NCT05351788 | A Phase Ⅱ Clinical Study of Combination Therapy of SKB264 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer. | ||
| NCT05311397 | A Study of A166 in Patients With Advanced Solid Malignant Tumors | ||
| NCT04835142 | Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC | ||
| NCT03426371 | Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial | ||
| NCT03017807 | Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer | ||
| NCT05445908 | SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer | ||
| NCT05347134 | SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer | ||
| NCT05294172 | KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma | ||
| NCT03848286 | KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma | ||
| NCT03580564 | An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma |
